TransCode Therapeutics, Inc.
RNAZ
$6.73
-$0.27-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.44M | -4.86M | -4.28M | -12.09M | -5.92M |
| Total Depreciation and Amortization | 44.80K | 4.80K | 13.40K | 51.20K | 122.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.92M | 413.50K | 293.20K | 9.39M | 1.70M |
| Change in Net Operating Assets | 340.60K | 354.60K | -224.50K | -455.10K | 942.30K |
| Cash from Operations | -8.14M | -4.08M | -4.19M | -3.10M | -3.15M |
| Capital Expenditure | -6.70K | -- | -- | -- | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.20K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.40K | -- | -- | -- | -500.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 8.85M | 7.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 22.67M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 455.70K | -455.70K | -- | -- | -- |
| Cash from Financing | 23.12M | -455.70K | 0.00 | 8.85M | 7.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.98M | -4.54M | -4.19M | 5.76M | 3.94M |